NEFL and Parkinson disease: In a recent study of PD subtypes, a biomarker-based approach revealed that plasma neurofilament light chain (NFL) was increased in the diffuse malignant subtype and was also associated with more rapid clinical progression of symptoms (Pilotto et al. 2021).